Authors:
Meyskens, FL
McNulty, SE
Buckmeier, JA
Tohidian, NB
Spillane, TJ
Kahlon, RS
Gonzalez, RI
Citation: Fl. Meyskens et al., Aberrant redox regulation in human metastatic melanoma cells compared to normal melanocytes, FREE RAD B, 31(6), 2001, pp. 799-808
Authors:
Newby, LK
Kaplan, AL
Tuttle, RH
McNulty, SE
Ohman, EM
Storrow, AB
Gibler, WB
Citation: Lk. Newby et al., Bedside multimarker testing for risk stratification in chest pain units: The chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) study - Response, CIRCULATION, 104(22), 2001, pp. E125-E126
Authors:
Newby, LK
Storrow, AB
Gibler, WB
Garvey, JL
Tucker, JF
Kaplan, AL
Schreiber, DH
Tuttle, RH
McNulty, SE
Ohman, M
Citation: Lk. Newby et al., Bedside multimarker testing for risk stratification in chest pain units - The chest pain evaluation by creatine Kinase-MB, myoglobin, and troponin I (CHECKMATE) study, CIRCULATION, 103(14), 2001, pp. 1832-1837
Authors:
McNulty, SE
Kline, B
Welsh, J
Bartkowski, R
Citation: Se. Mcnulty et al., Radiofrequency transmission to monitoring devices in the operating room: Asimulation study, ANESTH ANAL, 92(2), 2001, pp. 384-388
Authors:
Shah, MR
Stinnett, SS
McNulty, SE
Gheorghiade, M
Zannad, F
Uretsky, B
Adams, KF
Califf, RM
O'Connor, CM
Citation: Mr. Shah et al., Hemodynamics as surrogate end points for survival in advanced heart failure: An analysis from FIRST, AM HEART J, 141(6), 2001, pp. 908-914
Authors:
O'Connor, CM
Gattis, WA
Zannad, F
McNulty, SE
Gheorghiade, M
Adams, KF
Califf, RM
McKenna, WJ
Soler-Soler, J
Swedberg, K
Citation: Cm. O'Connor et al., Beta-blocker therapy in advanced heart failure: clinical characteristics and long-term outcomes, EUR J HE FA, 1(1), 1999, pp. 81-88
Authors:
Meyskens, FL
Buckmeier, JA
McNulty, SE
Tohidian, NB
Citation: Fl. Meyskens et al., Activation of nuclear factor-kappa B in human metastatic melanoma cells and the effect of oxidative stress, CLIN CANC R, 5(5), 1999, pp. 1197-1202
Authors:
O'Connor, CM
Gattis, WA
Uretsky, BF
Adams, KF
McNulty, SE
Grossman, SH
McKenna, WJ
Zannad, F
Swedberg, K
Gheorghiada, M
Califf, RM
Citation: Cm. O'Connor et al., Continuous intravenous dobutamine is associated with an increased risk of death in patients advanced heart failure: Insights from the Flolan International Randomized Survival Trial (FIRST), AM HEART J, 138(1), 1999, pp. 78-86